Should you buy ARTV stock?
Last updated:
Based on market data through , StockInvest.us rates Artiva Biotherapeutics, Inc. Common Stock (ARTV) as a Strong Buy Candidate with a technical score of 7.42 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Buy signal since
- Price since signal Up 24.49%
- 3-month trend forecast Up 9.37%
- +303.8% price growth over the last year
- +174.0% YTD performance
- Bullish trend confirmed on both short and long timeframes
High volatility in Artiva Biotherapeutics, Inc. Common stock price on Wednesday which ended trading at $11.59
(Market data through Aug 05, 2026)
The Artiva Biotherapeutics, Inc. Common stock price gained 4.70% on the last trading day (Wednesday, 5th Aug 2026), rising from $11.07 to $11.59. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 10.29% from a day low at $10.65 to a day high of $11.74. The price has risen in 7 of the last 10 days and is up by 15.67% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 154 thousand more shares were traded than the day before. In total, 548 thousand shares were bought and sold for approximately $6.36 million.
The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.37% during the next 3 months and, with a 90% probability hold a price between $8.26 and $14.95 at the end of this 3-month period.
ARTV Signals & Forecast
Mostly positive signals in the chart today. The Artiva Biotherapeutics, Inc. Common stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $10.64 and $9.79. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 70.44%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Artiva Biotherapeutics, Inc. Common stock
On the downside, the stock finds support just below today's level from accumulated volume at $10.89 and $9.82. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Artiva Biotherapeutics, Inc. Common finds support just below today's level at $10.89. If this is broken, then the next support from accumulated volume will be at $9.82 and $9.62.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.10 between high and low, or 10.29%. For the last week, the stock has had daily average volatility of 8.21%.
Our recommended stop-loss: $11.18 (-3.54%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 40 days ago.)
Trading Expectations (ARTV) For The Upcoming Trading Day Of Thursday 6th
For the upcoming trading day on Thursday, 6th we expect Artiva Biotherapeutics, Inc. Common Stock to open at $11.33, and during the day (based on 14 day Average True Range), to move between $11.15 and $12.03, which gives a possible trading interval of +/-$0.87 (+/-7.81%) up or down from last closing price. If Artiva Biotherapeutics, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 7.81% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $10.89 (6.04%) than the resistance at $12.39 (6.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Artiva Biotherapeutics, Inc. Common Stock stock A Buy?
Artiva Biotherapeutics, Inc. Common holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
Current score:
7.423
Strong Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 6, 2026 - $11.33 ( 2.29%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ARTV Performance
Trading levels for ARTV
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 12.42 | 7.16% |
| R2 | 12.00 | 3.55% |
| R1 | 11.74 | 1.32% |
| Price | 11.59 | |
| S1 | 10.91 | -5.90% |
| S2 | 10.65 | -8.13% |
| S3 | 10.23 | -11.73% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 12.52 | 8.02% |
| R1 | 12.39 | 6.90% |
| Price | 11.59 | |
| S1 | 10.89 | -6.04% |
| S2 | 9.82 | -15.27% |
| S3 | 9.62 | -17.00% |
FAQ
Click here for our free guide on how to buy Artiva Biotherapeutics, Inc. Common Stock Stock.
Buy ARTV